
A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY
Publication
, Conference
Fangusaro, J; Onar-Thomas, A; Poussaint, TY; Wu, S; Ligon, AH; Lindeman, N; Banerjee, A; Packer, RJ; Kilburn, LB; Pollack, IF; Jakacki, RI ...
Published in: NEURO-ONCOLOGY
June 1, 2017
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
June 1, 2017
Volume
19
Start / End Page
34 / 35
Location
New York, NY
Publisher
OXFORD UNIV PRESS INC
Conference Name
4th Biennial Conference on Pediatric Neuro-Oncology Basic and Translational Research
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Fangusaro, J., Onar-Thomas, A., Poussaint, T. Y., Wu, S., Ligon, A. H., Lindeman, N., … Fouladi, M. (2017). A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY. In NEURO-ONCOLOGY (Vol. 19, pp. 34–35). New York, NY: OXFORD UNIV PRESS INC.
Fangusaro, Jason, Arzu Onar-Thomas, Tina Y. Poussaint, Shengjie Wu, Azra H. Ligon, Neal Lindeman, Anu Banerjee, et al. “A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY.” In NEURO-ONCOLOGY, 19:34–35. OXFORD UNIV PRESS INC, 2017.
Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, et al. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2017. p. 34–5.
Fangusaro, Jason, et al. “A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY.” NEURO-ONCOLOGY, vol. 19, OXFORD UNIV PRESS INC, 2017, pp. 34–35.
Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Pollack IF, Jakacki RI, Qaddoumi I, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Pfister SM, Jones DTW, Vezina G, Stern J, Panigrahy A, Jones BV, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Doyle LA, Smith M, Boyett JM, Dunkel IJ, Fouladi M. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2017. p. 34–35.

Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
June 1, 2017
Volume
19
Start / End Page
34 / 35
Location
New York, NY
Publisher
OXFORD UNIV PRESS INC
Conference Name
4th Biennial Conference on Pediatric Neuro-Oncology Basic and Translational Research
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences